FIELD: medicine.
SUBSTANCE: invention refers to medicine and covers life span estimate for the treated patients suffering from mucinous ovarian carcinoma. Life span for the expectancy of patients suffering from mucinous ovarian carcinoma is predicted by estimating some morphological tumour parametres. Life span in months is evaluated by formula: LS(month)=58.15-0.187*X1-0.108*X2+0.707*X3-5.104*X4 where X1 is the average area of tumour cell (mcm2) measured by an eyepiece micrometre or a television image analyser; X2 is the average area of tumour stroma vessels (mcm2) counted by eyepiece micrometre or a television image analyser; X3 is a number of free cells of tumour stroma (piece) counted up per 10000 mcm2 of stroma area with using a television image analyser; X4 is a volume concentration of necrosis in tumour node (%) measured with morphometric grids or a television image analyser.
EFFECT: higher accuracy of life span evaluation in patients suffering from mucinous ovarian carcinoma; reduction of number of calculated variables, makes it possible to apply the method in planning the management tactics, and also in the therapeutic decision.
2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREDICTING LIFE DURATION OF PATIENTS SUFFERING FROM CHOLANGIOGENIC HEPATIC CARCINOMA | 2001 |
|
RU2202957C1 |
PREDICTION METHOD OF LIFE DURATION IN PATIENTS WITH MESONEPHROID OVARIAN CARCINOMA | 2008 |
|
RU2357672C1 |
METHOD FOR PREDICTING SEROUS OVARIAN CARCINOMA PATIENTS SURVIVAL PERIOD IN CLIMACTERIC PERIOD AND POSTMENOPAUSE | 2005 |
|
RU2291435C1 |
METHOD FOR PREDICTING LIFE DURATION IN PATIENTS WITH SEROUS RELAPSING OVARIAN CARCINOMA | 2005 |
|
RU2297788C1 |
METHOD FOR PREDICTING THE DURATION OF RELAPSE-FREE PERIOD IN PATIENTS WITH SEROSAL OVARIAN CANCER | 2005 |
|
RU2299018C1 |
METHOD FOR PREDICTING SURVIVAL PERIOD IN SEROUS OVARY CARCINOMA PATIENTS OF REPRODUCTIVE AGE | 2005 |
|
RU2290640C1 |
MESONEPHROID OVARIAN CARCINOMA SPREAD PREDICTION METHOD | 2008 |
|
RU2354302C1 |
METHOD FOR PREDICTING THE RELAPSE OF SEROUS OVARIAN CANCER | 2005 |
|
RU2290078C1 |
METHOD FOR PREDICTION OF PROBABILITY OF POSSIBLE EXECUTION OF OPTIMUM CYTOREDUCTIVE OPERATION IN PATIENTS WITH DISSEMINATED FORMS OF OVARIAN CANCER | 2017 |
|
RU2637399C1 |
METHOD FOR PREDICTING LIFE DURATION IN PATIENTS WITH HEPATICCELLULAR CARCINOMA | 2001 |
|
RU2207573C2 |
Authors
Dates
2009-05-10—Published
2008-01-09—Filed